stockrowRelay Therapeutics, Inc.
RLAY Healthcare Biotechnology
Relay Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $15.4 million, up 53.4% from fiscal 2024.
- Revenue
- −95.4%
- EPS
- 0.00%
- Free cash flow
- +2.13%
Quarter to June 2026, against a year earlier
Follow RLAY
Alert me
Relay Therapeutics, Inc. (RLAY) Operating margin
Relay Therapeutics, Inc.'s operating margin over the twelve months to 30 June 2026 was −2,815.5%, down 843.9 percentage points from fiscal 2025 (−1,971.6%). Over the past ten years it has ranged from −21,670.9% (fiscal 2022) to 0.00% (fiscal 2019); the current reading is higher than 50% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −1,971.6% | 1,750.48 |
| FY2024 | −3,722.1% | (2,261.96) |
| FY2023 | −1,460.1% | 20,210.78 |
| FY2022 | −21,670.9% | (9,630.68) |
| FY2021 | −12,040.2% | (11,972.70) |
| FY2020 | −67.5% | (67.51) |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | −25,949.7% | (23,330.04) |
| Mar 2026 | −2,619.7% | (1,753.39) |
| Dec 2025 | −866.3% | (866.28) |
| Sep 2025 | 0.00% | 11,351.11 |
| 24 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| ACAD ACADIA Pharmaceuticals Inc. compare | 10.2% |
| XENE Xenon Pharmaceuticals Inc. compare | 0.00% |
| IRON Disc Medicine, Inc. compare | 0.00% |
| EWTX Edgewise Therapeutics, Inc. compare | 0.00% |
| PBLS Parabilis Medicines, Inc. compare | 0.00% |
| TNGX Tango Therapeutics, Inc. compare | 0.00% |
| IOVA Iovance Biotherapeutics, Inc. compare | −60.8% |
| ABCL AbCellera Biologics Inc. compare | −340.3% |
| RLAY Relay Therapeutics, Inc. | −2,815.5% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on RLAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement